• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Chief Financial Officer Callesano Christopher

    3/31/25 9:22:50 PM ET
    $MC
    Investment Managers
    Finance
    Get the next $MC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Callesano Christopher

    (Last) (First) (Middle)
    399 PARK AVE

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Moelis & Co [ MC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    03/27/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    2020 Incentive RSUs $0(1) 03/27/2025 A 4.65 (2) (2) Class A Common Stock 4.65 $0 431.11 D
    2021 Incentive RSUs $0(1) 03/27/2025 A 8.03 (3) (3) Class A Common Stock 8.03 $0 745.49 D
    2022 Incentive RSUs $0(1) 03/27/2025 A 18.99 (4) (4) Class A Common Stock 18.99 $0 1,762.2 D
    2023 Incentive RSUs $0(1) 03/27/2025 A 17.4 (5) (5) Class A Common Stock 17.4 $0 1,614.13 D
    2024 Incentive RSUs $0(1) 03/27/2025 A 17.36 (6) (6) Class A Common Stock 17.36 $0 1,610.36 D
    Explanation of Responses:
    1. Each Restricted Stock Unit ("RSU") represents the right to receive upon settlement either, at Moelis & Company's option, a share of Class A common stock or an amount of cash equal to the fair market value of such share.
    2. Incentive RSUs were issued as dividend equivalents on the holder's unvested underlying Incentive RSUs issued on February 19, 2021 (and dividend equivalents subsequently issued thereon). The dividend equivalent Incentive RSUs will vest concurrently with the vesting of the unvested underlying Incentive RSUs.
    3. Incentive RSUs were issued as dividend equivalents on the holder's unvested underlying Incentive RSUs issued on February 17, 2022 (and dividend equivalents subsequently issued thereon). The dividend equivalent Incentive RSUs will vest concurrently with the vesting of the unvested underlying Incentive RSUs.
    4. Incentive RSUs were issued as dividend equivalents on the holder's unvested underlying Incentive RSUs issued on February 16, 2023 (and dividend equivalents subsequently issued thereon). The dividend equivalent Incentive RSUs will vest concurrently with the vesting of the unvested underlying Incentive RSUs.
    5. Incentive RSUs were issued as dividend equivalents on the holder's unvested underlying Incentive RSUs issued on February 15, 2024 (and dividend equivalents subsequently issued thereon). The dividend equivalent Incentive RSUs will vest concurrently with the vesting of the unvested underlying Incentive RSUs.
    6. Incentive RSUs were issued as dividend equivalents on the holder's unvested underlying Incentive RSUs issued on February 13, 2025 (and dividend equivalents subsequently issued thereon). The dividend equivalent Incentive RSUs will vest concurrently with the vesting of the unvested underlying Incentive RSUs.
    /s/ Osamu Watanabe as attorney-in-fact for Christopher Callesano 03/31/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MC

    DatePrice TargetRatingAnalyst
    3/13/2025$100.00 → $70.00Overweight → Underweight
    Morgan Stanley
    12/20/2024$71.00 → $86.00Mkt Perform → Outperform
    Keefe Bruyette
    12/9/2024$66.00 → $92.00Underweight → Overweight
    Morgan Stanley
    9/12/2024$70.00Equal Weight
    Wells Fargo
    3/13/2024$53.00 → $58.00Sell → Neutral
    Goldman
    1/29/2024$56.00Mkt Perform
    Keefe Bruyette
    1/11/2023$40.00 → $37.00Neutral → Sell
    Goldman
    11/3/2022$40.00 → $37.00Mkt Perform → Underperform
    Keefe Bruyette
    More analyst ratings

    $MC
    SEC Filings

    See more
    • SEC Form 8-K filed by Moelis & Company

      8-K - Moelis & Co (0001596967) (Filer)

      6/9/25 8:00:21 AM ET
      $MC
      Investment Managers
      Finance
    • SEC Form 8-K filed by Moelis & Company

      8-K - Moelis & Co (0001596967) (Filer)

      6/6/25 5:00:28 PM ET
      $MC
      Investment Managers
      Finance
    • Moelis & Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Moelis & Co (0001596967) (Filer)

      4/23/25 4:16:15 PM ET
      $MC
      Investment Managers
      Finance

    $MC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Moelis downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Moelis from Overweight to Underweight and set a new price target of $70.00 from $100.00 previously

      3/13/25 8:13:34 AM ET
      $MC
      Investment Managers
      Finance
    • Moelis upgraded by Keefe Bruyette with a new price target

      Keefe Bruyette upgraded Moelis from Mkt Perform to Outperform and set a new price target of $86.00 from $71.00 previously

      12/20/24 7:43:45 AM ET
      $MC
      Investment Managers
      Finance
    • Moelis upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Moelis from Underweight to Overweight and set a new price target of $92.00 from $66.00 previously

      12/9/24 7:57:53 AM ET
      $MC
      Investment Managers
      Finance